Target intelligence / Profile preview

Cyclin-dependent kinase 2 pseudogene

Molecular classification
Pseudogene, Other
01

Overview

Cyclin-dependent kinase 2 pseudogene is a genomic sequence similar to the protein-coding gene for cyclin-dependent kinase 2 (CDK2) but is classified as a pseudogene, meaning it has lost its ability to encode a functional protein through evolutionary mutations or gene duplication. Pseudogenes are generally incapable of participating in biological processes such as cell cycle regulation, unlike their protein-coding counterparts. They are usually considered "junk DNA" but may be transcribed at low levels; however, there is no evidence that the cyclin-dependent kinase 2 pseudogene has any regulatory or protein-coding function relevant for pharmacology, signaling, or disease[1][3]. If you aim to extract structured information for therapeutic targeting, this entry should be excluded due to lack of protein product, biological function, or role as a valid molecular target.

Other names
Cyclin-dependent kinase 2 pseudogeneCDK2 pseudogeneENSG00000257825 (Ensembl ID)
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Cyclin-dependent kinase 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin-dependent kinase 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call